secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEOGENOMICS INC (NEO)
CIK:        0001077183
Form:       8-K
Filed at:   2025-01-15T23:59:59+00:00
Accession:  0001077183-25-000007
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeoGenomics guides 2025 revenue $735-745M, adj. EBITDA $55-58M; issues retention bonuses
--------------------------------------------------------------------------------

- 2025 revenue guidance $735-745M (midpoint $740M) vs FY24 $661M, ~12% YoY growth.
- 2025 adjusted EBITDA guidance $55-58M vs FY24 $38.5M, up 43-51%.
- Long-range plan: 12-13% annual revenue growth; NGS growth ~25% per year.
- Retention bonuses: CFO Sherman ($400K cash + $750K RSUs), Presidents Harris and Stone each similar with vesting thru 2026.
- Expects to retire 2025 convertible notes due May 1 with cash on hand.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1077183/000107718325000007/0001077183-25-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1077183/000107718325000007/neo-20250114.htm
  HTML page:      https://secwatch.observer/filing/0001077183-25-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer